These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4286889)

  • 1. Biophysical studies of vesicular stomatitis virus.
    McCombs RM; Melnick MB; Brunschwig JP
    J Bacteriol; 1966 Feb; 91(2):803-12. PubMed ID: 4286889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between infectivity and physical virus particles in human cytomegalovirus.
    Benyesh-Melnick M; Probstmeyer F; McCombs R; Brunschwig JP; Vonka V
    J Bacteriol; 1966 Nov; 92(5):1555-61. PubMed ID: 4288610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of vesicular stomatitis virus particles: implications for virion assembly.
    Lodish HF; Porter M
    J Virol; 1980 Jan; 33(1):52-8. PubMed ID: 6245248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of low infectivity vesicular stomatitis virus particles from tunicamycin-treated cells.
    Maheshwari RK; Singh VK; Husain MM; Friedman RM; Mohanty SB
    J Exp Pathol; 1985; 2(3):149-63. PubMed ID: 3023584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restitution of infectivity to spikeless vesicular stomatitis virus by solubilized viral components.
    Bishop DH; Repik P; Obijeski JF; Moore NF; Wagner RR
    J Virol; 1975 Jul; 16(1):75-84. PubMed ID: 166210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteins of vesicular stomatitis virus and of phenotypically mixed vesicular stomatitis virus-simian virus 5 virions.
    McSharry JJ; Compans RW; Choppin PW
    J Virol; 1971 Nov; 8(5):722-9. PubMed ID: 4108932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of virosomes coated with the vesicular stomatitis virus glycoprotein as efficient gene transfer vehicles for animal cells.
    Shoji J; Tanihara Y; Uchiyama T; Kawai A
    Microbiol Immunol; 2004; 48(3):163-74. PubMed ID: 15031529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of seven picornaviruses of man.
    Jamison RM; Mayor HD
    J Bacteriol; 1966 May; 91(5):1971-6. PubMed ID: 4287079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cells that express all five proteins of vesicular stomatitis virus from cloned cDNAs support replication, assembly, and budding of defective interfering particles.
    Pattnaik AK; Wertz GW
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1379-83. PubMed ID: 1847519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV-lipoprotein complexes in human serum and complement-dependent viral lysis.
    Mills BJ; Beebe DP; Cooper NR
    J Immunol; 1979 Dec; 123(6):2518-24. PubMed ID: 227957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low infectivity of vesicular stomatitis virus (VSV) particles released from interferon-treated cells is related to glycoprotein deficiency.
    Maheshwari RK; Husain MM; Friedman RM
    Biochem Biophys Res Commun; 1983 Nov; 117(1):161-8. PubMed ID: 6318745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles.
    Dalton KP; Rose JK
    Virology; 2001 Jan; 279(2):414-21. PubMed ID: 11162797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstitution of infectivity and transcriptase activity of homologous and heterologous viruses: vesicular stomatitis (Indiana serotype), Chandipura, vesicular stomatitis (New Jersey serotype), and Cocal viruses.
    Bishop DH; Emerson SU; Flamand A
    J Virol; 1974 Jul; 14(1):139-44. PubMed ID: 4365327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-treated cells release vesicular stomatitis virus particles lacking glycoprotein spikes: correlation with biochemical data.
    Maheshwari RK; Demsey AE; Mohanty SB; Friedman RM
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2284-7. PubMed ID: 6154948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-layered membrane vesicles released from mammalian cells infected with Sendai virus expressing the matrix protein of vesicular stomatitis virus.
    Sakaguchi T; Uchiyama T; Fujii Y; Kiyotani K; Kato A; Nagai Y; Kawai A; Yoshida T
    Virology; 1999 Oct; 263(1):230-43. PubMed ID: 10544097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphogenesis of the nucleoprotein of vesicular stomatitis virus.
    Zajac BA; Hummeler K
    J Virol; 1970 Aug; 6(2):243-52. PubMed ID: 4100528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementation of M gene mutants of vesicular stomatitis virus by plasmid-derived M protein converts spherical extracellular particles into native bullet shapes.
    Lyles DS; McKenzie MO; Kaptur PE; Grant KW; Jerome WG
    Virology; 1996 Mar; 217(1):76-87. PubMed ID: 8599238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infective virus substructure from vesicular stomatitis virus.
    Brown F; Cartwright B; Crick J; Smale CJ
    J Virol; 1967 Apr; 1(2):368-73. PubMed ID: 4318952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biophysical properties of frog virus and its deoxyribonucleic acid: fate of radioactive virus in the early stage of infection.
    Smith WR; McAuslan BR
    J Virol; 1969 Oct; 4(4):339-47. PubMed ID: 4980848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane fusion activity, oligomerization, and assembly of the rabies virus glycoprotein.
    Whitt MA; Buonocore L; Prehaud C; Rose JK
    Virology; 1991 Dec; 185(2):681-8. PubMed ID: 1660200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.